De Novo Cohort for Chronic Pain

Pacific Sports and Spine, LLC, Eugene, OR
Chronic PainNeurostimulation System - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a certain kind of electrical stimulation can help relieve chronic pain for people with certain kinds of medical conditions.

Eligible Conditions
  • Chronic Pain

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 months

6 months
Pain Intensity

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

De Novo Cohort
1 of 2
Existing Cohort
1 of 2

Active Control

1900 Total Participants · 2 Treatment Groups

Primary Treatment: De Novo Cohort · No Placebo Group · N/A

De Novo Cohort
Device
ActiveComparator Group · 1 Intervention: Neurostimulation System · Intervention Types: Device
Existing Cohort
Device
ActiveComparator Group · 1 Intervention: Neurostimulation System · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

Boston Scientific CorporationLead Sponsor
685 Previous Clinical Trials
922,669 Total Patients Enrolled
31 Trials studying Chronic Pain
64,471 Patients Enrolled for Chronic Pain
Natalie Bloom Lyons, M.S.Study DirectorBoston Scientific Neuromodulation Corporation
1 Previous Clinical Trials
1,500 Total Patients Enrolled
1 Trials studying Chronic Pain
1,500 Patients Enrolled for Chronic Pain
Roshini Jain, M.S.Study DirectorBoston Scientific Neuromodulation Corporation
3 Previous Clinical Trials
1,764 Total Patients Enrolled
3 Trials studying Chronic Pain
1,764 Patients Enrolled for Chronic Pain

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Oregon50.0%
Florida50.0%
What site did they apply to?
Tallahassee Neurological Clinic, PA50.0%
Pacific Sports and Spine, LLC50.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%
Why did patients apply to this trial?
  • "I have been prescribed gabapentin and meloxicam and had zero relief. I have been diagnosed with ankylosing spondylitis. I am looking for other ways to manage this pain."
How many prior treatments have patients received?
1100.0%

Frequently Asked Questions

How many locales are currently executing this experiment?

"This medical research is being conducted across 13 distinct sites. These locations, which include Eugene, New Orleans and Carlsbad, are spread throughout the nation in order to facilitate participant accessibility; it is recommended that those interested join the closest trial hub they can find." - Anonymous Online Contributor

Unverified Answer

How many test subjects are partaking in this medical experiment?

"Correct. According to clinicaltrials.gov, this investigation is still seeking participants after being posted on July 31st 2017 and revised November 2nd 2022; it requires 1900 volunteers from 13 different locations for the trial's completion." - Anonymous Online Contributor

Unverified Answer

Are there any available openings for potential participants in this clinical research?

"Affirmative. Clinicaltrials.gov records demonstrate that this trial, which was initially listed on July 31st 2017, is actively recruiting individuals for participation. The study seeks to enrol 1,900 patients across 13 different sites." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.